Cinpanemab Biosimilar - Research Grade

Human

SNCAï؟½

5mg/ml

IgG1 - lambda2

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P37840;P37840;O55042;P37377

Blue ice

Alpha-synuclein (SNCA) is a presynaptic protein whose aggregation into Lewy bodies is a hallmark studied across Parkinson's disease and synucleinopathy research. This reagent is an unconjugated, non-therapeutic analog of cinpanemab, a human IgG1-lambda recombinant antibody supplied for research use only. It is formulated with low endotoxin to in vivo-grade standards and manufactured in scalable milligram-to-gram quantities for high-throughput neuroscience laboratories. It supports functional and binding assays, alpha-synuclein aggregation and seeding studies, in vitro screening and preclinical models of synucleinopathy, with reliable performance across lots. As a research-use-only reagent, it combines a low-endotoxin in vivo-grade format with scalable milligram-to-gram production for demanding studies.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks